Get the Stockscreener App
73.95
1.57%
-1.18
After Hours:
73.95
Prestige Consumer Healthcare Inc stock is traded at $73.95, with a volume of 396.96K.
It is down -1.57% in the last 24 hours and down -7.39% over the past month.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
See More
Previous Close:
$75.13
Open:
$74.48
24h Volume:
396.96K
Relative Volume:
1.03
Market Cap:
$3.64B
Revenue:
$1.11B
Net Income/Loss:
$205.95M
P/E Ratio:
17.99
EPS:
4.11
Net Cash Flow:
$254.64M
1W Performance:
-3.05%
1M Performance:
-7.39%
6M Performance:
-3.67%
1Y Performance:
+4.43%
1-Day Range:
$73.67
$75.63
1-Week Range:
$73.67
$77.03
52-Week Range:
$64.94
$90.04
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Name
Prestige Consumer Healthcare Inc
Sector
Phone
(914) 524-6800
Address
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
73.95 | 3.70B | 1.11B | 205.95M | 254.64M | 4.11 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Downgrade | Sidoti | Buy → Neutral |
| Jun-21-24 | Upgrade | DA Davidson | Neutral → Buy |
| Nov-17-22 | Initiated | Canaccord Genuity | Buy |
| May-10-22 | Upgrade | Jefferies | Hold → Buy |
| May-09-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-07-20 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-29-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-14-20 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-20 | Resumed | Sidoti | Neutral |
| Mar-26-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-24-20 | Initiated | Oppenheimer | Perform |
| Mar-19-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-04-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jun-02-17 | Upgrade | Jefferies | Underperform → Hold |
| May-22-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-27-16 | Reiterated | B. Riley & Co. | Buy |
| Nov-17-16 | Initiated | Gabelli & Co | Buy |
| Aug-12-16 | Upgrade | Sidoti | Neutral → Buy |
| Mar-08-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Feb-05-16 | Initiated | Piper Jaffray | Overweight |
| Nov-30-15 | Downgrade | Jefferies | Hold → Underperform |
| Apr-28-14 | Reiterated | B. Riley & Co. | Buy |
| Apr-28-14 | Reiterated | Oppenheimer | Outperform |
| Jul-09-13 | Initiated | B. Riley & Co. | Buy |
View All
Prestige Consumer Healthcare Inc Stock (PBH) Latest News
Is Prestige Consumer Healthcare Inc. a growth stock or a value stockAdvanced Screener Growth Plan For Fast Growth - jammulinksnews.com
XTX Topco Ltd Purchases 17,761 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Applying Wyckoff theory to Prestige Consumer Healthcare Inc. stockFree High Accuracy Alerts for ROI Traders - Newser
Prestige Consumer Healthcare Inc. stock trendline breakdownAlgorithmic Forecast for Swing Trading Picks - Newser
Market reaction to Prestige Consumer Healthcare Inc.’s recent newsDaily Market Entry Strategy with Tools - Newser
Risk adjusted return profile for Prestige Consumer Healthcare Inc. analyzed3-Day Market Movement Forecast Analysis - Newser
Analyzing Prestige Consumer Healthcare Inc. with risk reward ratio chartsFree High Win Rate Trading Opportunities - Newser
Detecting support and resistance levels for Prestige Consumer Healthcare Inc.Free AI Based High Gain Watchlist Scanner - Newser
When is the best time to exit Prestige Consumer Healthcare Inc.Free Stock Selection With High Accuracy - Newser
Will Prestige Consumer Healthcare Inc. Benefit From Sector TailwindsStable Entry High Return Opportunities in Focus - metal.it
Volume Profile Shows Strong Base for Prestige Consumer Healthcare Inc.Market Momentum Signal Generator Shows Trends - metal.it
Why Prestige Consumer Healthcare Inc. stock attracts strong analyst attentionStock Market Watch with Smart Filters - Newser
How many analysts rate Prestige Consumer Healthcare Inc. as a “Buy”Invest with confidence backed by data - jammulinksnews.com
How volatile is Prestige Consumer Healthcare Inc. stock compared to the marketInvest smarter and grow your wealth faster - jammulinksnews.com
How does Prestige Consumer Healthcare Inc. compare to its industry peersAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
Prestige Consumer Healthcare (PBH) Stock Analysis: A 15% Upside Potential Amid Steady Growth - DirectorsTalk Interviews
Detecting support and resistance levels for Prestige Consumer Healthcare Inc. Free Smart Trend Trading with Weekly Signals - Newser
Why Prestige Consumer Healthcare Inc. stock attracts strong analyst attention Price Spike Prediction for Active Traders - Newser
What is Prestige Consumer Healthcare Inc. company’s growth strategyAchieve consistent double-digit returns - jammulinksnews.com
Cerity Partners LLC Raises Position in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Should I hold or sell Prestige Consumer Healthcare Inc. stock in 2025Get daily expert analysis on top stocks - jammulinksnews.com
Why is Prestige Consumer Healthcare Inc. stock attracting strong analyst attentionFree Stock Movement Tracking - jammulinksnews.com
What is the dividend policy of Prestige Consumer Healthcare Inc. stockCapitalize on emerging industry trends - jammulinksnews.com
What catalysts could drive Prestige Consumer Healthcare Inc. stock higher in 2025Get exclusive access to professional stock picks - jammulinksnews.com
What analysts say about Prestige Consumer Healthcare Inc. stockConsistent double returns - PrintWeekIndia
Is Prestige Consumer Healthcare Inc. a good long term investmentExtraordinary performance - PrintWeekIndia
Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives $93.33 Average Price Target from Brokerages - Defense World
Published on: 2025-07-25 08:02:27 - PrintWeekIndia
What drives Prestige Consumer Healthcare Inc. stock priceRapid wealth accumulation - Autocar Professional
Prestige Consumer Healthcare Inc. Stock Analysis and ForecastHigh-profit stock alerts - jammulinksnews.com
Prestige Consumer Healthcare Inc. (PBH) Reinvents Retail Strategy for the Digital Age - MSN
Prestige Consumer Healthcare Announces Q1 Earnings Release Date - AInvest
Prestige Consumer Healthcare Inc Stock (PBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):